Merck KGaA Follows Pfizer With Archemix Deal For Aptamer-Based Therapeutics
This article was originally published in The Pink Sheet Daily
Executive Summary
German drug maker's new subsidiary, Merck Serono, will oversee development of aptamer-based drugs to treat cancer.